Clinical Trial Update: A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial Lung Disease Associated With Antisynthetase Syndrome [NA]

View source ↗

Summary

A clinical trial update outlining a comparative study of JAK inhibitors versus calcineurin inhibitors as initial therapy for interstitial lung disease associate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antisynthetase Syndrome
• Interstitial Lung Disease

Drugs mentioned

• Calcineurin inhibitors
• JAK inhibitors (Janus kinase inhibitors)

Snippet

Sponsor: China-Japan Friendship Hospital | Conditions: Antisynthetase Syndrome, Interstitial Lung Disease (ILD) | NA | Status: NOT_YET_RECRUITING